Growth Metrics

Quest Diagnostics (DGX) Depreciation and Depletion (2016 - 2026)

Quest Diagnostics' Depreciation and Depletion history spans 18 years, with the latest figure at $110.0 million for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion rose 8.91% to $110.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $425.0 million, a 11.84% increase, with the full-year FY2025 number at $416.0 million, up 13.66% from a year prior.
  • Depreciation and Depletion hit $110.0 million in Q1 2026 for Quest Diagnostics, up from $108.0 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for DGX hit a ceiling of $110.0 million in Q1 2026 and a floor of $77.0 million in Q4 2022.
  • Historically, Depreciation and Depletion has averaged $90.6 million across 5 years, with a median of $87.0 million in 2024.
  • Biggest five-year swings in Depreciation and Depletion: decreased 3.75% in 2022 and later grew 19.51% in 2024.
  • Tracing DGX's Depreciation and Depletion over 5 years: stood at $77.0 million in 2022, then grew by 6.49% to $82.0 million in 2023, then increased by 19.51% to $98.0 million in 2024, then increased by 10.2% to $108.0 million in 2025, then grew by 1.85% to $110.0 million in 2026.
  • Business Quant data shows Depreciation and Depletion for DGX at $110.0 million in Q1 2026, $108.0 million in Q4 2025, and $103.0 million in Q3 2025.